Fuller & Thaler Asset Management
PRAH

Fuller & Thaler Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Fuller & Thaler Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-458,144
Closed -$75.7M – 562
2021
Q2 		$75.7M Buy
458,144
+7,548
+2% +$1.26M 0.49% 68
2021
Q1 		$69.1M Buy
450,596
+568
+0.1% +$77.1K 0.49% 68
2020
Q4 		$56.5M Sell
450,028
-1,587
-0.4% -$177K 0.52% 67
2020
Q3 		$45.8M Buy
451,615
+1,815
+0.4% +$185K 0.58% 63
2020
Q2 		$43.8M Buy
449,800
+242,348
+117% +$22.6M 0.57% 65
2020
Q1 		$17.2M Buy
207,452
+155,344
+298% +$15.2M 0.29% 106
2019
Q4 		$5.79M Buy
52,108
+21,579
+71% +$2.22M 0.06% 208
2019
Q3 		$3.03M Buy
30,529
+46
+0.2% +$4.57K 0.04% 248
2019
Q2 		$3.02M Buy
30,483
+46
+0.2% +$4.39K 0.04% 241
2019
Q1 		$3.36M Buy
30,437
+1,022
+3% +$107K 0.04% 222
2018
Q4 		$2.71M Sell
29,415
-31,025
-51% -$3.14M 0.04% 242
2018
Q3 		$6.66M Sell
60,440
-67,860
-53% -$7.07M 0.07% 189
2018
Q2 		$12M Buy
128,300
+5,000
+4% +$431K 0.13% 135
2018
Q1 		$10.2M Buy
123,300
+8,300
+7% +$737K 0.12% 135
2017
Q4 		$10.5M Buy
115,000
+61,700
+116% +$5.13M 0.13% 120
2017
Q3 		$4.06M Buy
53,300
+32,200
+153% +$2.43M 0.05% 188
2017
Q2 		$1.58M Buy
21,100
+11,300
+115% +$783K 0.02% 247
2017
Q1 		$639K Buy
9,800
+2,100
+27% +$124K 0.01% 295
2016
Q4 		$424K Buy
7,700
+5,500
+250% +$302K 0.01% 310
2016
Q3 		$124K Buy
+2,200
New +$108K ﹤0.01% 424

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Fuller & Thaler Asset Management's PRAH Position: Q3 2021 in Review

Fuller & Thaler Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 458,144 shares — an estimated $75.7M sold.

Fuller & Thaler Asset Management first reported a position in PRAH in Q3 2016 and held it in 20 quarters. The position peaked at $75.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Fuller & Thaler Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 458,144 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $75.7M.
  • Fuller & Thaler Asset Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 20 quarters.
  • Fuller & Thaler Asset Management's PRA Health Sciences, Inc. position peaked at $75.7M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.